Chemoinformaics analysis of Hydroxymetasequirin A
| Molecular Weight | 334.324 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 17 |
| Exact Molecular Weight | 334.105 | nRing | 3 |
| Solubility: LogS | -2.422 | nHRing | 1 |
| Solubility: LogP | 0.419 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 46.0063 |
| nHD | 6 | BPOL | 19.7937 |
| QED | 0.463 |
| Synth | 3.886 |
| Natural Product Likeliness | 1.305 |
| NR-PPAR-gamma | 0.061 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.131 |
| HIA | 0.473 |
| CACO-2 | -5.625 |
| MDCK | 0.00000535 |
| BBB | 0.078 |
| PPB | 0.873931 |
| VDSS | 0.666 |
| FU | 0.189257 |
| CYP1A2-inh | 0.077 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.163 |
| CYP2c9-sub | 0.479 |
| CYP2d6-inh | 0.082 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.123 |
| CYP3a4-sub | 0.147 |
| CL | 15.032 |
| T12 | 0.846 |
| hERG | 0.034 |
| Ames | 0.483 |
| ROA | 0.21 |
| SkinSen | 0.948 |
| Carcinogencity | 0.263 |
| EI | 0.917 |
| Respiratory | 0.212 |
| NR-Aromatase | 0.516 |
| Antiviral | Yes |
| Prediction | 0.749358 |